We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONO icon
1076
Sonos
SONO
$1.79B
$40K ﹤0.01%
2,959
+446
+18% +$5.58K
LEE icon
1077
Lee Enterprises
LEE
$171M
$39K ﹤0.01%
+1,926
New +$39.3K
OFLX icon
1078
Omega Flex
OFLX
$258M
$39K ﹤0.01%
379
+108
+40% +$8.96K
RBB icon
1079
RBB Bancorp
RBB
$449M
$39K ﹤0.01%
1,999
+716
+56% +$13.7K
ANIP icon
1080
ANI Pharmaceuticals
ANIP
$1.62B
$38K ﹤0.01%
515
+183
+55% +$13.7K
BGSF icon
1081
BGSF Inc
BGSF
$55M
$37K ﹤0.01%
1,956
+583
+42% +$10.8K
GNE icon
1082
Genie Energy
GNE
$415M
$37K ﹤0.01%
4,966
+2,563
+107% +$22.4K
NVEC icon
1083
NVE Corp
NVEC
$486M
$37K ﹤0.01%
+565
New +$38.5K
FCBP
1084
DELISTED
First Choice Bancorp Common Stock
FCBP
$37K ﹤0.01%
+1,722
New +$37.3K
GHDX
1085
DELISTED
Genomic Health, Inc.
GHDX
$37K ﹤0.01%
551
-1,132
-67% -$77.7K
FRAF icon
1086
Franklin Financial Services
FRAF
$285M
$36K ﹤0.01%
+1,013
New +$35.6K
HDSN
1087
Hudson Technologies
HDSN
$227M
$36K ﹤0.01%
50,000
RLGT icon
1088
Radiant Logistics
RLGT
$384M
$36K ﹤0.01%
6,900
+3,143
+84% +$16.3K
INBK icon
1089
First Internet Bancorp
INBK
$245M
$35K ﹤0.01%
1,612
+589
+58% +$12.1K
PKBK icon
1090
Parke Bancorp
PKBK
$408M
$35K ﹤0.01%
+1,755
New +$36.2K
SEI
1091
Solaris Energy Infrastructure
SEI
$4.02B
$35K ﹤0.01%
+2,592
New +$35.4K
SCPL
1092
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$35K ﹤0.01%
3,226
+1,469
+84% +$16.1K
EPM icon
1093
Evolution Petroleum
EPM
$133M
$33K ﹤0.01%
5,682
+2,090
+58% +$12.8K
FSBW icon
1094
FS Bancorp
FSBW
$340M
$32K ﹤0.01%
1,234
+446
+57% +$11K
HWBK icon
1095
Hawthorn Bancshares
HWBK
$291M
$32K ﹤0.01%
+1,549
New +$31.8K
RVLV icon
1096
Revolve Group
RVLV
$1.46B
$31K ﹤0.01%
+1,343
New +$38.4K
FNCB
1097
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$31K ﹤0.01%
+3,967
New +$30.5K
CTO
1098
CTO Realty Growth
CTO
$776M
$30K ﹤0.01%
1,695
+490
+41% +$8.41K
HSKA
1099
DELISTED
Heska Corp
HSKA
$29K ﹤0.01%
412
+168
+69% +$12.6K
COLL icon
1100
Collegium Pharmaceutical
COLL
$741M
$28K ﹤0.01%
2,481
+1,013
+69% +$11.6K

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.